Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
about
Noninvasive fetal genotyping of human platelet antigen-1a.How I manage neonatal thrombocytopenia.Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.Usefulness of maternal anti-HPA-1a antibody quantitation in predicting severity of foetomaternal alloimmune thrombocytopenia.Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.Current perspectives on fetal and neonatal alloimmune thrombocytopenia - increasing clinical concerns and new treatment opportunities.
P2860
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@ast
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@en
type
label
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@ast
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@en
prefLabel
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@ast
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@en
P2093
P2860
P1476
Fetal alloimmune thrombocytopenia: is less invasive antenatal management safe?
@en
P2093
Agnes Mechoulan
Bernard Branger
Cecile Kaplan
French GROG
Henri Jean Philippe
Jean Yves Muller
Jean-Francois Oury
Norbert Winer
P2860
P304
P356
10.3109/14767058.2010.511333
P50
P577
2010-09-07T00:00:00Z